Literature DB >> 19281793

Mouse CD4+ CD25+ T regulatory cells are protected from autologous complement mediated injury by Crry and CD59.

Qing Li1, Kristine Nacion, Hong Bu, Feng Lin.   

Abstract

Self cells depend on surface complement regulators to protect them from autologous complement mediated attack. CD4(+)CD25(+)foxp3(+) T regulatory (Treg) cells are critical in maintaining immune homeostasis, however, which complement regulators are expressed on them and how they are protected from autologous complement attack remains unknown. We report here that mouse Treg cells express virtually no DAF or CR1. Instead, all of them express Crry and approximately half of them express CD59. Both Crry(-/-) and CD59(-/-) Treg cells exhibit greater complement mediated injury than WT Treg cells. These results clarify the status of cell surface complement regulators on mouse Treg cells and indicate that both Crry and CD59 are required to protect Treg cells from autologous complement mediated injury. Additionally, these data also argue that different from previous assumption, at least in mice, CD4(+)CD25(+)foxp3(+) Treg cells are not homogenous and could be further divided into subgroups based on CD59 expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19281793      PMCID: PMC2696126          DOI: 10.1016/j.bbrc.2009.03.025

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

1.  Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria.

Authors:  D S Holt; M Botto; A E Bygrave; S M Hanna; M J Walport; B P Morgan
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

2.  Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection.

Authors:  Feng Lin; Henry J Kaminski; Bianca M Conti-Fine; Wei Wang; Chelliah Richmonds; M Edward Medof
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

3.  Membrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins.

Authors:  E R Podack; G Biesecker; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

4.  Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis.

Authors:  Feng Lin; Steven N Emancipator; David J Salant; M Edward Medof
Journal:  Lab Invest       Date:  2002-05       Impact factor: 5.662

5.  Covalent binding and hemolytic activity of complement proteins.

Authors:  S K Law; N A Lichtenberg; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

6.  Role of the complement receptor CR1 in the processing of substrate-bound C3.

Authors:  M E Medof; K Iida; V Nussenzweig
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

Review 7.  CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases.

Authors:  Xavier Valencia; Peter E Lipsky
Journal:  Nat Clin Pract Rheumatol       Date:  2007-11

8.  The role of membrane receptors for C3b and C3d in phagocytosis.

Authors:  A G Ehlenberger; V Nussenzweig
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

9.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Authors:  T Seya; J R Turner; J P Atkinson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

10.  Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.

Authors:  M E Medof; T Kinoshita; V Nussenzweig
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  1 in total

1.  Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.

Authors:  Zhidan Tu; Qing Li; Hong-Shiue Chou; Ching-Chuang Hsieh; Howard Meyerson; Marion G Peters; Hong Bu; John J Fung; Shiguang Qian; Lina Lu; Feng Lin
Journal:  Immunobiology       Date:  2010-08-19       Impact factor: 3.144

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.